David Shek M.d.,inc. | |
1401 S Anaheim Blvd Anaheim CA 92805-6214 | |
(714) 772-9800 | |
(714) 772-6800 |
Full Name | David Shek M.d.,inc. |
---|---|
Speciality | Clinic/Center |
Location | 1401 S Anaheim Blvd, Anaheim, California |
Authorized Official Name and Position | David Shek (PRESIDENT) |
Authorized Official Contact | 7147729800 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
David Shek M.d.,inc. 1401 S Anaheim Blvd Anaheim CA 92805-6214 Ph: (714) 772-9800 | David Shek M.d.,inc. 1401 S Anaheim Blvd Anaheim CA 92805-6214 Ph: (714) 772-9800 |
NPI Number | 1245319631 |
---|---|
Provider Enumeration Date | 11/04/2006 |
Last Update Date | 06/07/2013 |
Medicare PECOS PAC ID | 0345324356 |
---|---|
Medicare Enrollment ID | O20080229000286 |
News Archive
The American Society for Radiation Oncology (ASTRO) is proud to announce the publication of Safety is No Accident: A Framework for Quality Radiation Oncology and Care, a comprehensive book detailing minimum recommended guidelines for radiation oncology practices.
Rexahn Pharmaceuticals, Inc. has announced that it has received FDA approval to begin Phase II trials for Archexin, the Company's leading cancer compound, for the treatment of pancreatic cancer.
Bronchiectasis is independently associated with an increased mortality risk in patients with moderate-to-severe COPD, according to a new study from researchers in Spain.
A form of cell communication called hedgehog signaling is vital for embryonic development in mammals.
According to the United States Centers for Disease Control and Prevention, over 800,000 Americans die each year from heart disease and stroke. Stroke is the leading cause of serious long-term disability and death in the US. In addition to lifestyle changes, medications such as anti-blood clotting drugs are helpful in the prevention of stroke.
› Verified 6 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1245319631 | NPI | - | NPPES |
1346289915 | Other | CA | NPI FOR DAVID SHEK M.D. |
1245319631 | Other | CA | NPI FOR DAVID SHEK MD INC |
00A309450 | Medicaid | CA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
261QP2300X | Clinic/center - Primary Care | A30945 (California) | Primary |
Provider Name | David Y Shek |
---|---|
Provider Type | Practitioner - General Practice |
Provider Identifiers | NPI Number: 1346289915 PECOS PAC ID: 0345324349 Enrollment ID: I20080229000276 |
News Archive
The American Society for Radiation Oncology (ASTRO) is proud to announce the publication of Safety is No Accident: A Framework for Quality Radiation Oncology and Care, a comprehensive book detailing minimum recommended guidelines for radiation oncology practices.
Rexahn Pharmaceuticals, Inc. has announced that it has received FDA approval to begin Phase II trials for Archexin, the Company's leading cancer compound, for the treatment of pancreatic cancer.
Bronchiectasis is independently associated with an increased mortality risk in patients with moderate-to-severe COPD, according to a new study from researchers in Spain.
A form of cell communication called hedgehog signaling is vital for embryonic development in mammals.
According to the United States Centers for Disease Control and Prevention, over 800,000 Americans die each year from heart disease and stroke. Stroke is the leading cause of serious long-term disability and death in the US. In addition to lifestyle changes, medications such as anti-blood clotting drugs are helpful in the prevention of stroke.
› Verified 6 days ago
News Archive
The American Society for Radiation Oncology (ASTRO) is proud to announce the publication of Safety is No Accident: A Framework for Quality Radiation Oncology and Care, a comprehensive book detailing minimum recommended guidelines for radiation oncology practices.
Rexahn Pharmaceuticals, Inc. has announced that it has received FDA approval to begin Phase II trials for Archexin, the Company's leading cancer compound, for the treatment of pancreatic cancer.
Bronchiectasis is independently associated with an increased mortality risk in patients with moderate-to-severe COPD, according to a new study from researchers in Spain.
A form of cell communication called hedgehog signaling is vital for embryonic development in mammals.
According to the United States Centers for Disease Control and Prevention, over 800,000 Americans die each year from heart disease and stroke. Stroke is the leading cause of serious long-term disability and death in the US. In addition to lifestyle changes, medications such as anti-blood clotting drugs are helpful in the prevention of stroke.
› Verified 6 days ago
The Family Medicine Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1211 W. La Palma Avenue, Suite #404, Anaheim, CA 92801 Phone: 714-772-1030 Fax: 714-772-1758 | |
Anaheim Medical Group Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2571 W La Palma Ave, Anaheim, CA 92801 Phone: 714-827-9797 Fax: 714-827-5377 | |
Shirdi Medical Corporation Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1751 W Romneya Dr, Anaheim, CA 92801 Phone: 714-776-3180 Fax: 714-991-1932 | |
Rakesh Kumar Bhola ,m.d. Inc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 1781 W Romneya Dr Ste C, Anaheim, CA 92801 Phone: 714-776-2700 | |
Anaheim Health Care Center Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 1125 N Magnolia Ave, Anaheim, CA 92801 Phone: 714-484-1280 Fax: 714-484-1358 | |
Richard Dick M Yip Md A Medical Corp Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 408 S Beach Blvd Ste 211, Anaheim, CA 92804 Phone: 714-527-6000 Fax: 714-527-2371 | |
Benevolence Health Center Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 303 N East St, Anaheim, CA 92805 Phone: 714-491-1771 |